Answers are grounded in this paper and cite their sources.
Background. Diabetic nephropathy (DN) is a major cause of end-stage renal disease globally. Knowledge of the role of deficiency in 25-hydroxyvitamin D (25(OH)D) as well as dysregulation of insulin-like growth factor 1 (IGF-1) levels and increased malnutrition-inflammation score (MIS) in the pathogenesis and progression of DN remains important. Vitamin D receptor (VDR) and insulin-like growth factor-binding protein 3 (IGFBP-3) gene expression is molecular basis that remains incompletely characterized. The purpose of the study was to assess serum 25(OH)D, MIS, and IGF-1 in relation to peripheral blood mononuclear cell mRNA expression of VDR and IGFBP-3 in patients with type 2 diabetes mellitus (T2DM), with and without nephropathy, and to determine their diagnostic performance using receiver operating characteristic analysis. Materials and methods. A cross-sectional case-control study enrolled 160 participants equally distributed into four groups (n = 40 each): group I — healthy controls (HC); group II — T2DM without DN; group III — T2DM with microalbuminuric DN; group IV — T2DM with macroalbuminuric DN. Serum 25(OH)D was measured by enzyme-linked immunosorbent assay; MIS was determined via validated score; serum IGF-1 was quantified by immunoassay. VDR and IGFBP-3 mRNA expression in peripheral blood mononuclear cells was assessed by quantitative real-time polymerase chain reaction using the 2–∆∆Ct method with GAPDH as the reference gene. Additional biochemical parameters including HbA1c, fasting blood glucose, serum creatinine, estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio, lipid profile, and complete blood count were determined. Results. Serum 25(OH)D and IGF-1 levels decreased progressively from group I to group IV (p < 0.001), whereas MIS increased significantly (p < 0.001). VDR mRNA expression was significantly downregulated in DN patients (group IV: 0.21 ± 0.04 vs. group I: 1.00 ± 0.06, p < 0.001), exhibiting a strong positive correlation with serum 25(OH)D (r = 0.847, p < 0.001) and eGFR (r = 0.793, p < 0.001). In contrast, IGFBP-3 mRNA increased progressively with DN severity (group IV = 3.87 ± 0.29 vs. group I = 1.00 ± 0.08; p < 0.001) and correlated inversely with serum IGF-1 (r = –0.832, p < 0.001). Receiver operating characteristic analysis showed eGFR as its strongest single discriminator (AUC = 0.891), followed by VDR mRNA (AUC = 0.879), serum 25(OH)D (AUC = 0.871), IGFBP-3 mRNA (AUC = 0.865), MIS (AUC = 0.853). Conclusions. Significant alterations in serum 25(OH)D, MIS, IGF-1, and VDR and IGFBP-3 gene expression characterize diabetic nephropathy and track its severity.
No takes yet. Share an insight, caveat, or question.
Ali2 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: